{
    "doi": "https://doi.org/10.1182/blood.V116.21.3574.3574",
    "article_title": "Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia ",
    "article_date": "November 19, 2010",
    "session_type": "CLL - Biology and Pathophysiology, excluding Therapy: Poster III",
    "abstract_text": "Abstract 3574 Chronic lymphocytic leukemia (B-CLL) is a very heterogeneous disease with some patients experiencing rapid disease progression and others living for years without requiring treatment and therefore it is mandatory to find new prognostic markers. CD69 overexpression which resembles B cells at an earlier and greater state of activation (Damle, 2002 and 2007) and induces increased proliferation and survival of leukemic B-lymphocytes, may reflect an aggressive and progressive clinical outcome. The primary endpoints of our research were: 1) to determine progression free survival (PFS) and overall survival (OS) upon CD69 in univariate analysis; 2) to correlate CD69 with other clinical or biological prognostic factors such as age, Rai stages, lymphocyte doubling time, beta-2 microglobulin, CD38, CD49d, ZAP-70, cytogenetics by FISH and IgVH status and finally, 3) to confirm CD69 as an independent prognostic factor. We investigated 417 patients (pts), median age 66 years (range 33\u201389), 239 males and 178 females. With regard to modified Rai stages, 127 pts had a low stage, 272 an intermediate stage and 18 a high stage. CD69 was determined by multicolor flow cytometry, fixing the cut-off value at 30%. CD69+ pts were 111/417 (26.6%). CD69 12 months (260/337; P=0.0006), beta-2 microglobulin  or <60 years (P=0.001), CD69 (P=0.004), ZAP-70 (P=0.01) and CD38 (P=0.03) were identified as significant. Noteworthy, here, we demonstrated that CD69 is able to improve the historical prognostic ability of the IgVH mutational status. Since the IgVH mutated subset represents a large and heterogeneous population with a variable progression, CD69 may better define prognosis within this subgroup. Therefore, CD69, determined by flow cytometry, should be considered a novel important prognostic parameter in B-CLL and has to be necessarily added in a new scoring prognostic system. In fact, its easy and rapid laboratory determination allows us to identify early progressive pts in order to take timely therapeutic decisions. View large Download slide View large Download slide  Close modal Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "chronic b-cell leukemias",
        "chronic lymphocytic leukemia",
        "brachial plexus neuritis",
        "zap-70 kinase",
        "prognostic factors",
        "beta 2-microglobulin",
        "flow cytometry",
        "cd23 antigen",
        "chemotherapy regimen",
        "disease progression"
    ],
    "author_names": [
        "Giovanni Del Poeta",
        "Maria Ilaria Del Principe",
        "Pietro Bulian",
        "Cristina Simotti",
        "Francesco Buccisano, MD",
        "Fabrizio Luciano",
        "Antonella Zucchetto",
        "Licia Ottaviani",
        "Luca Maurillo",
        "Chiara Sarlo",
        "Annalisa Biagi",
        "Laura Gianni\u0300",
        "Alessio Pio Perrotti",
        "Adriano Venditti",
        "Paolo de Fabritiis",
        "Valter Gattei",
        "Sergio Amadori"
    ],
    "author_dict_list": [
        {
            "author_name": "Giovanni Del Poeta",
            "author_affiliations": [
                "Division of Hematology, S.Eugenio Hospital and University of Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Maria Ilaria Del Principe",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pietro Bulian",
            "author_affiliations": [
                "Clinical and Experimental Hematology Research Unit, Centro di Riferimento Oncologico, IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cristina Simotti",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Buccisano, MD",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizio Luciano",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonella Zucchetto",
            "author_affiliations": [
                "Clinical and Experimental Hematology Research Unit, Centro di Riferimento Oncologico, IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Licia Ottaviani",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luca Maurillo",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Sarlo",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Annalisa Biagi",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laura Gianni\u0300",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessio Pio Perrotti",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Adriano Venditti",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo de Fabritiis",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Valter Gattei",
            "author_affiliations": [
                "Clinical and Experimental Hematology Research Unit, Centro di Riferimento Oncologico, IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sergio Amadori",
            "author_affiliations": [
                "Hematology, University Tor Vergata, Roma, Italy, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-15T21:28:58",
    "is_scraped": "1"
}